Showing results (11-20 of 60) with videos related to
Sort By:
Pageof 6
Journal of Clinical Pharmacology|July 7, 2007
Lopinavir/Ritonavir pharmacokinetic profile: impact of sex and other covariates following a change from twice-daily to once-daily therapyIghovwerha Ofotokun, Susan K Chuck, Jose N Binongo, et al.Journal of Virology|July 15, 2005
Diversity, divergence, and evolution of cell-free human immunodeficiency virus type 1 in vaginal secretions and blood of chronically infected women: associations with immune statusSharon T Sullivan, Usha Mandava, Tammy Evans-Strickfaden, et al.Journal of Neurovirology|June 2, 2016
Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairmentAlbert M Anderson, Jeffrey L Lennox, Minh L Nguyen, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2018
Measurement of Human Immunodeficiency Virus p24 Antigen in Human Cerebrospinal Fluid With Digital Enzyme-Linked Immunosorbent Assay and Association With Decreased Neuropsychological PerformanceAlbert M Anderson, William R Tyor, Mark J Mulligan, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2003
Macrolide-resistant pneumococcal endocarditis and epidural abscess that develop during erythromycin therapyJay C Butler, Jeffrey L Lennox, Linda K McDougal, et al.BMC International Health and Human Rights|February 26, 2010
Culturally-adapted and audio-technology assisted HIV/AIDS awareness and education program in rural Nigeria: a cohort studyIghovwerha Ofotokun, Jose Nilo G Binongo, Eli S Rosenberg, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2002
Increased survival of persons with tuberculosis and human immunodeficiency virus infection, 1991--2000Michael K Leonard, Nina Larsen, Henning Drechsler, et al.AIDS (London, England)|July 20, 2002
Viral load response to a pneumococcal conjugate vaccine, polysaccharide vaccine or placebo among HIV-infected patientsMatthew Bidwell Goetz, Daniel R Feikin, Jeffrey L Lennox, et al.Clinical Pharmacokinetics|December 7, 2013
Integrated population pharmacokinetic/viral dynamic modelling of lopinavir/ritonavir in HIV-1 treatment-naïve patientsKun Wang, David Z D'Argenio, Edward P Acosta, et al.Open Forum Infectious Diseases|July 17, 2015
Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for HyperbilirubinemiaSaran Vardhanabhuti, Heather J Ribaudo, Raphael J Landovitz, et al.Pageof 6